CD33 and neoplasm: Zhang et al. further confirmed a positive correlation between high levels of tumor-infiltrating T-MDSCs (CD33+CD11b+HLA-DR−) and advanced disease stage (p < 0.05), with the percentage of T-MDSCs significantly higher in the tumor tissues compared to the peripheral blood of BC patients [39].